| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ABHD16A | ACSL4 | ENSPTRP00000076853 | ENSPTRP00000038175 | Abhydrolase domain containing 16A. | Acyl-CoA synthetase long-chain family member 4. | 0.800 |
| ABHD16A | ACSL6 | ENSPTRP00000076853 | ENSPTRP00000088489 | Abhydrolase domain containing 16A. | T0093412 isoform 1. | 0.800 |
| ABHD16A | LIPC | ENSPTRP00000076853 | ENSPTRP00000051465 | Abhydrolase domain containing 16A. | Lipase C, hepatic type. | 0.902 |
| ABHD16A | LPL | ENSPTRP00000076853 | ENSPTRP00000034315 | Abhydrolase domain containing 16A. | Lipoprotein lipase; Key enzyme in triglyceride metabolism. Catalyzes the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and thereby plays an important role in lipid clearance from the blood stream, lipid utilization and storage. Mediates margination of triglyceride-rich lipoprotein particles in capillaries. Recruited to its site of action on the luminal surface of vascular endothelium by binding to GPIHBP1 and cell surface heparan sulfate proteoglycans. | 0.900 |
| ABHD16A | MGLL | ENSPTRP00000076853 | ENSPTRP00000071389 | Abhydrolase domain containing 16A. | Monoglyceride lipase. | 0.908 |
| ACSL4 | ABHD16A | ENSPTRP00000038175 | ENSPTRP00000076853 | Acyl-CoA synthetase long-chain family member 4. | Abhydrolase domain containing 16A. | 0.800 |
| ACSL4 | ACSL6 | ENSPTRP00000038175 | ENSPTRP00000088489 | Acyl-CoA synthetase long-chain family member 4. | T0093412 isoform 1. | 0.730 |
| ACSL4 | FASN | ENSPTRP00000038175 | ENSPTRP00000016660 | Acyl-CoA synthetase long-chain family member 4. | Fatty acid synthase. | 0.938 |
| ACSL4 | LIPC | ENSPTRP00000038175 | ENSPTRP00000051465 | Acyl-CoA synthetase long-chain family member 4. | Lipase C, hepatic type. | 0.607 |
| ACSL4 | LPL | ENSPTRP00000038175 | ENSPTRP00000034315 | Acyl-CoA synthetase long-chain family member 4. | Lipoprotein lipase; Key enzyme in triglyceride metabolism. Catalyzes the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and thereby plays an important role in lipid clearance from the blood stream, lipid utilization and storage. Mediates margination of triglyceride-rich lipoprotein particles in capillaries. Recruited to its site of action on the luminal surface of vascular endothelium by binding to GPIHBP1 and cell surface heparan sulfate proteoglycans. | 0.847 |
| ACSL4 | MGLL | ENSPTRP00000038175 | ENSPTRP00000071389 | Acyl-CoA synthetase long-chain family member 4. | Monoglyceride lipase. | 0.859 |
| ACSL4 | PPT1 | ENSPTRP00000038175 | ENSPTRP00000093126 | Acyl-CoA synthetase long-chain family member 4. | Palmitoyl-protein thioesterase 1. | 0.845 |
| ACSL4 | PPT2 | ENSPTRP00000038175 | ENSPTRP00000030749 | Acyl-CoA synthetase long-chain family member 4. | PPT2-EGFL8 isoform 1. | 0.839 |
| ACSL6 | ABHD16A | ENSPTRP00000088489 | ENSPTRP00000076853 | T0093412 isoform 1. | Abhydrolase domain containing 16A. | 0.800 |
| ACSL6 | ACSL4 | ENSPTRP00000088489 | ENSPTRP00000038175 | T0093412 isoform 1. | Acyl-CoA synthetase long-chain family member 4. | 0.730 |
| ACSL6 | CDC42SE2 | ENSPTRP00000088489 | ENSPTRP00000043959 | T0093412 isoform 1. | CDC42 small effector 2. | 0.753 |
| ACSL6 | CLMP | ENSPTRP00000088489 | ENSPTRP00000081318 | T0093412 isoform 1. | CXADR-like membrane protein. | 0.763 |
| ACSL6 | FASN | ENSPTRP00000088489 | ENSPTRP00000016660 | T0093412 isoform 1. | Fatty acid synthase. | 0.932 |
| ACSL6 | LIPC | ENSPTRP00000088489 | ENSPTRP00000051465 | T0093412 isoform 1. | Lipase C, hepatic type. | 0.765 |
| ACSL6 | LPL | ENSPTRP00000088489 | ENSPTRP00000034315 | T0093412 isoform 1. | Lipoprotein lipase; Key enzyme in triglyceride metabolism. Catalyzes the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and thereby plays an important role in lipid clearance from the blood stream, lipid utilization and storage. Mediates margination of triglyceride-rich lipoprotein particles in capillaries. Recruited to its site of action on the luminal surface of vascular endothelium by binding to GPIHBP1 and cell surface heparan sulfate proteoglycans. | 0.846 |
